

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.59026826 |
| 2 | central nervous system myelination (GO:0022010) | 5.37558963 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 5.37558963 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.27060178 |
| 5 | cellular extravasation (GO:0045123) | 4.94473612 |
| 6 | neutrophil mediated immunity (GO:0002446) | 4.38710124 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.27824965 |
| 8 | negative T cell selection (GO:0043383) | 4.20455710 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.09639855 |
| 10 | regulation of cell maturation (GO:1903429) | 4.08020839 |
| 11 | histone H3-K4 trimethylation (GO:0080182) | 4.07065945 |
| 12 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.00815674 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96049487 |
| 14 | presynaptic membrane assembly (GO:0097105) | 3.95348271 |
| 15 | myeloid leukocyte mediated immunity (GO:0002444) | 3.93720753 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91014938 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 3.91014938 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91014938 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91014938 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91014938 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 3.91014938 |
| 22 | neural tube formation (GO:0001841) | 3.88654630 |
| 23 | positive T cell selection (GO:0043368) | 3.79312547 |
| 24 | presynaptic membrane organization (GO:0097090) | 3.76275067 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 3.74253542 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.67431596 |
| 27 | response to interleukin-15 (GO:0070672) | 3.66582087 |
| 28 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.58474484 |
| 29 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.58024653 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54324512 |
| 31 | neutrophil activation (GO:0042119) | 3.49947830 |
| 32 | glycerophospholipid catabolic process (GO:0046475) | 3.49641194 |
| 33 | histone-serine phosphorylation (GO:0035404) | 3.48959623 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.48069947 |
| 35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.40547798 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.40458435 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.34037180 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.32215289 |
| 39 | detection of other organism (GO:0098543) | 3.30733293 |
| 40 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.25651308 |
| 41 | mannosylation (GO:0097502) | 3.25350424 |
| 42 | activated T cell proliferation (GO:0050798) | 3.24467004 |
| 43 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23853208 |
| 44 | interferon-gamma production (GO:0032609) | 3.22552980 |
| 45 | respiratory burst (GO:0045730) | 3.22342072 |
| 46 | macrophage activation (GO:0042116) | 3.19615157 |
| 47 | protein K11-linked deubiquitination (GO:0035871) | 3.15940536 |
| 48 | granulocyte activation (GO:0036230) | 3.15299785 |
| 49 | positive regulation of protein homodimerization activity (GO:0090073) | 3.14555203 |
| 50 | cellular response to ethanol (GO:0071361) | 3.12327935 |
| 51 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.11116087 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.09722688 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09554494 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.08766081 |
| 55 | positive regulation of synapse assembly (GO:0051965) | 3.08160159 |
| 56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.06599385 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.05763241 |
| 58 | leukocyte aggregation (GO:0070486) | 3.04102039 |
| 59 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.03731646 |
| 60 | detection of external biotic stimulus (GO:0098581) | 3.02140945 |
| 61 | T cell selection (GO:0045058) | 2.99848341 |
| 62 | peptidyl-lysine trimethylation (GO:0018023) | 2.99358720 |
| 63 | developmental pigmentation (GO:0048066) | 2.98496073 |
| 64 | positive thymic T cell selection (GO:0045059) | 2.97558570 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 2.97374525 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96703741 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96621020 |
| 68 | negative regulation of neurotransmitter transport (GO:0051589) | 2.95859339 |
| 69 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94700421 |
| 70 | dopamine biosynthetic process (GO:0042416) | 2.94678040 |
| 71 | response to host immune response (GO:0052572) | 2.90620363 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90620363 |
| 73 | regulation of B cell differentiation (GO:0045577) | 2.88599398 |
| 74 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87999794 |
| 75 | T cell migration (GO:0072678) | 2.87019076 |
| 76 | chaperone-mediated protein transport (GO:0072321) | 2.86729282 |
| 77 | detection of bacterium (GO:0016045) | 2.86091800 |
| 78 | dendritic cell migration (GO:0036336) | 2.85692322 |
| 79 | response to host (GO:0075136) | 2.82367038 |
| 80 | response to host defenses (GO:0052200) | 2.82367038 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82367038 |
| 82 | fatty acid elongation (GO:0030497) | 2.81471133 |
| 83 | myelination (GO:0042552) | 2.80945328 |
| 84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80712239 |
| 85 | GPI anchor metabolic process (GO:0006505) | 2.78401326 |
| 86 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.78109740 |
| 87 | RNA destabilization (GO:0050779) | 2.77516884 |
| 88 | response to peptidoglycan (GO:0032494) | 2.76983768 |
| 89 | protein localization to cilium (GO:0061512) | 2.76302038 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75723702 |
| 91 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.75650818 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.75569860 |
| 93 | regulation of pigment cell differentiation (GO:0050932) | 2.73434123 |
| 94 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.72435939 |
| 95 | GPI anchor biosynthetic process (GO:0006506) | 2.72213918 |
| 96 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.72163644 |
| 97 | axon ensheathment (GO:0008366) | 2.72034763 |
| 98 | ensheathment of neurons (GO:0007272) | 2.72034763 |
| 99 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.71548453 |
| 100 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.71347309 |
| 101 | superoxide anion generation (GO:0042554) | 2.70104024 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70056659 |
| 103 | hepatocyte apoptotic process (GO:0097284) | 2.70017213 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 2.68987189 |
| 105 | tolerance induction (GO:0002507) | 2.67969405 |
| 106 | dopamine transport (GO:0015872) | 2.67237640 |
| 107 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.67149062 |
| 108 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.66486540 |
| 109 | neurotransmitter uptake (GO:0001504) | 2.66427956 |
| 110 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.65671021 |
| 111 | negative regulation of adaptive immune response (GO:0002820) | 2.64414437 |
| 112 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.61843049 |
| 113 | T cell proliferation (GO:0042098) | 2.61311817 |
| 114 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.61023686 |
| 115 | epithelial cilium movement (GO:0003351) | 2.61023124 |
| 116 | histone H2B ubiquitination (GO:0033523) | 2.59989463 |
| 117 | lymphoid progenitor cell differentiation (GO:0002320) | 2.58978106 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58071659 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.57062507 |
| 120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56755757 |
| 121 | positive regulation of DNA recombination (GO:0045911) | 2.56532483 |
| 122 | positive regulation of isotype switching (GO:0045830) | 2.55950712 |
| 123 | ribosomal small subunit biogenesis (GO:0042274) | 2.55520012 |
| 124 | regulation of catecholamine metabolic process (GO:0042069) | 2.54893145 |
| 125 | regulation of dopamine metabolic process (GO:0042053) | 2.54893145 |
| 126 | vitamin catabolic process (GO:0009111) | 2.54409783 |
| 127 | fat-soluble vitamin catabolic process (GO:0042363) | 2.54409783 |
| 128 | cilium movement (GO:0003341) | 2.54105055 |
| 129 | transmission of nerve impulse (GO:0019226) | 2.51542246 |
| 130 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.49626875 |
| 131 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.48739876 |
| 132 | protein localization to synapse (GO:0035418) | 2.48309738 |
| 133 | microtubule polymerization or depolymerization (GO:0031109) | 2.47236370 |
| 134 | oligodendrocyte differentiation (GO:0048709) | 2.46880850 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.46532457 |
| 136 | mast cell activation (GO:0045576) | 2.46459899 |
| 137 | negative regulation of exocytosis (GO:0045920) | 2.43512355 |
| 138 | nonmotile primary cilium assembly (GO:0035058) | 2.43470747 |
| 139 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43199230 |
| 140 | natural killer cell activation involved in immune response (GO:0002323) | 2.42305222 |
| 141 | L-amino acid import (GO:0043092) | 2.40660365 |
| 142 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.40613188 |
| 143 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.40021390 |
| 144 | protein neddylation (GO:0045116) | 2.38583661 |
| 145 | neuron remodeling (GO:0016322) | 2.36682361 |
| 146 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.36233856 |
| 147 | regulation of activation of Janus kinase activity (GO:0010533) | 2.36044654 |
| 148 | leukocyte degranulation (GO:0043299) | 2.35829808 |
| 149 | positive regulation of T cell cytokine production (GO:0002726) | 2.30942724 |
| 150 | postsynaptic membrane organization (GO:0001941) | 2.30590021 |
| 151 | spermatid nucleus differentiation (GO:0007289) | 2.29714308 |
| 152 | glutamate receptor signaling pathway (GO:0007215) | 2.29306111 |
| 153 | mast cell activation involved in immune response (GO:0002279) | 2.28561092 |
| 154 | mast cell degranulation (GO:0043303) | 2.28561092 |
| 155 | microtubule depolymerization (GO:0007019) | 2.27509329 |
| 156 | regulation of mast cell activation (GO:0033003) | 2.26379621 |
| 157 | neuron recognition (GO:0008038) | 2.25888059 |
| 158 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.25053009 |
| 159 | negative regulation of cell killing (GO:0031342) | 2.25053009 |
| 160 | regulation of feeding behavior (GO:0060259) | 2.24263401 |
| 161 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.23267315 |
| 162 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.22968227 |
| 163 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.21133950 |
| 164 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.20795363 |
| 165 | regulation of timing of cell differentiation (GO:0048505) | 2.16902702 |
| 166 | regulation of T cell cytokine production (GO:0002724) | 2.16521745 |
| 167 | serotonin receptor signaling pathway (GO:0007210) | 2.15667886 |
| 168 | regulation of collateral sprouting (GO:0048670) | 2.14967021 |
| 169 | microglial cell activation (GO:0001774) | 2.12481543 |
| 170 | regulation of histone H3-K27 methylation (GO:0061085) | 2.12215185 |
| 171 | neutrophil activation involved in immune response (GO:0002283) | 2.11881255 |
| 172 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.10558499 |
| 173 | cellular response to interleukin-15 (GO:0071350) | 2.10420339 |
| 174 | centriole replication (GO:0007099) | 2.10285789 |
| 175 | limb bud formation (GO:0060174) | 2.10023008 |
| 176 | regulation of mast cell degranulation (GO:0043304) | 2.09646609 |
| 177 | glycolipid biosynthetic process (GO:0009247) | 2.09430945 |
| 178 | cellular response to gamma radiation (GO:0071480) | 2.09298087 |
| 179 | GTP biosynthetic process (GO:0006183) | 2.08974095 |
| 180 | positive regulation of interleukin-17 production (GO:0032740) | 2.08538406 |
| 181 | negative regulation of T cell mediated immunity (GO:0002710) | 2.08355997 |
| 182 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.07235932 |
| 183 | ATP synthesis coupled proton transport (GO:0015986) | 2.07235932 |
| 184 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.06712650 |
| 185 | C-terminal protein amino acid modification (GO:0018410) | 2.06382594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.42893247 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41552911 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.80842670 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.71717230 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.49420825 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.74955892 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.72573600 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.68660235 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.64556068 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.62081109 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60860144 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58181487 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57245202 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53335065 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52981991 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49552311 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.42419988 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.33714542 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32450997 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.28896060 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27959539 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.27294341 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25349405 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 2.24712027 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22316006 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18742490 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.08045211 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.05373597 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97298339 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95896372 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.95673978 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.93575466 |
| 33 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.92501277 |
| 34 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.91584023 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.90528722 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86179981 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81077987 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.80258590 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80172077 |
| 40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79987646 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77901332 |
| 42 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77883978 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76941441 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.76417347 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76331237 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76268667 |
| 47 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.70395787 |
| 48 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.70064183 |
| 49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.69860252 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.69765259 |
| 51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.67879616 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67829434 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66743938 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.66383630 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.65040625 |
| 56 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.64635953 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62529512 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61280782 |
| 59 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.61232093 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60391271 |
| 61 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.59977759 |
| 62 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58345766 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.58144086 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58063705 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56959199 |
| 66 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.56210035 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.55955916 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.54745904 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54745403 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54679743 |
| 71 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.53248516 |
| 72 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52694586 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50850001 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50571638 |
| 75 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48590194 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46424476 |
| 77 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45742520 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44698395 |
| 79 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.44027127 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.43309586 |
| 81 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.41937354 |
| 82 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.40368604 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40114059 |
| 84 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.39134451 |
| 85 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.38279140 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37513832 |
| 87 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.37245877 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36353570 |
| 89 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.35775099 |
| 90 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.35745306 |
| 91 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34816007 |
| 92 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.33729472 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31557834 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27588695 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27194869 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.26819735 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26184149 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26119288 |
| 99 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.25976197 |
| 100 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.25737500 |
| 101 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25106853 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24820646 |
| 103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.19043416 |
| 104 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18898890 |
| 105 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18898890 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18474271 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18474271 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17236182 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16635283 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15684349 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15537195 |
| 112 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.15179983 |
| 113 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13814372 |
| 114 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.12327201 |
| 115 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11300316 |
| 116 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11072574 |
| 117 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10792619 |
| 118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09901080 |
| 119 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09570470 |
| 120 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09250650 |
| 121 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08764571 |
| 122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08617080 |
| 123 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07989109 |
| 124 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.07207408 |
| 125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06520262 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05853982 |
| 127 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04833416 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03873738 |
| 129 | JUN_21703547_ChIP-Seq_K562_Human | 1.03315852 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02953189 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02637120 |
| 132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02183995 |
| 133 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01910982 |
| 134 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.01099505 |
| 135 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00855633 |
| 136 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.00430535 |
| 137 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00167219 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99932493 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98180592 |
| 140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96424584 |
| 141 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96398065 |
| 142 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96355602 |
| 143 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96287811 |
| 144 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95901873 |
| 145 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95582266 |
| 146 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95292842 |
| 147 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95229962 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95133369 |
| 149 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94470782 |
| 150 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93800239 |
| 151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92723690 |
| 152 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92723690 |
| 153 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91554870 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90954806 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90014011 |
| 156 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89527379 |
| 157 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.89312113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.22342266 |
| 2 | MP0003880_abnormal_central_pattern | 4.30783080 |
| 3 | MP0005409_darkened_coat_color | 3.18606359 |
| 4 | MP0002009_preneoplasia | 3.04497778 |
| 5 | MP0003136_yellow_coat_color | 2.85749843 |
| 6 | MP0005171_absent_coat_pigmentation | 2.67227576 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.50549268 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.47068844 |
| 9 | MP0003436_decreased_susceptibility_to | 2.30672970 |
| 10 | MP0004742_abnormal_vestibular_system | 2.20166909 |
| 11 | MP0001905_abnormal_dopamine_level | 2.07183120 |
| 12 | MP0000920_abnormal_myelination | 2.06654501 |
| 13 | MP0006082_CNS_inflammation | 1.98714180 |
| 14 | MP0000685_abnormal_immune_system | 1.96013058 |
| 15 | MP0008057_abnormal_DNA_replication | 1.95877231 |
| 16 | MP0005464_abnormal_platelet_physiology | 1.91380619 |
| 17 | MP0001188_hyperpigmentation | 1.90212411 |
| 18 | MP0001486_abnormal_startle_reflex | 1.90161717 |
| 19 | MP0005423_abnormal_somatic_nervous | 1.88864897 |
| 20 | MP0004381_abnormal_hair_follicle | 1.88280956 |
| 21 | MP0001529_abnormal_vocalization | 1.81574559 |
| 22 | MP0009745_abnormal_behavioral_response | 1.77459064 |
| 23 | MP0005410_abnormal_fertilization | 1.77212851 |
| 24 | * MP0006276_abnormal_autonomic_nervous | 1.77167548 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.75312656 |
| 26 | MP0002405_respiratory_system_inflammati | 1.74311109 |
| 27 | MP0004270_analgesia | 1.73747789 |
| 28 | MP0002398_abnormal_bone_marrow | 1.72924713 |
| 29 | MP0002102_abnormal_ear_morphology | 1.72266701 |
| 30 | MP0002064_seizures | 1.71604288 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.69978600 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.69942805 |
| 33 | MP0004142_abnormal_muscle_tone | 1.67778732 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.67176372 |
| 35 | MP0000371_diluted_coat_color | 1.66838780 |
| 36 | MP0000716_abnormal_immune_system | 1.65727871 |
| 37 | MP0002272_abnormal_nervous_system | 1.65176761 |
| 38 | MP0003303_peritoneal_inflammation | 1.64792978 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.64622213 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.64296566 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.62237410 |
| 42 | MP0002928_abnormal_bile_duct | 1.61555771 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.61395635 |
| 44 | MP0000372_irregular_coat_pigmentation | 1.58621245 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.56064267 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.52905410 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.51764821 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.51686908 |
| 49 | MP0002736_abnormal_nociception_after | 1.50901422 |
| 50 | MP0009046_muscle_twitch | 1.49543219 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.48249895 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.47800746 |
| 53 | MP0000778_abnormal_nervous_system | 1.46295178 |
| 54 | MP0002722_abnormal_immune_system | 1.44278942 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.41633296 |
| 56 | MP0001485_abnormal_pinna_reflex | 1.41459680 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.40632021 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.40557598 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.33444292 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.32903559 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.31018991 |
| 62 | MP0004883_abnormal_blood_vessel | 1.30893308 |
| 63 | MP0002938_white_spotting | 1.30811523 |
| 64 | MP0003866_abnormal_defecation | 1.29391255 |
| 65 | MP0004859_abnormal_synaptic_plasticity | 1.28432429 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.27235163 |
| 67 | MP0000383_abnormal_hair_follicle | 1.26579567 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.26011440 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.25830005 |
| 70 | MP0003828_pulmonary_edema | 1.25658754 |
| 71 | MP0009764_decreased_sensitivity_to | 1.25146675 |
| 72 | MP0001963_abnormal_hearing_physiology | 1.24908069 |
| 73 | MP0004885_abnormal_endolymph | 1.24601541 |
| 74 | MP0006054_spinal_hemorrhage | 1.23805023 |
| 75 | MP0002429_abnormal_blood_cell | 1.22572696 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.22468784 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.22095933 |
| 78 | MP0000427_abnormal_hair_cycle | 1.20213621 |
| 79 | MP0003724_increased_susceptibility_to | 1.19270985 |
| 80 | MP0002006_tumorigenesis | 1.18397893 |
| 81 | MP0005387_immune_system_phenotype | 1.18156431 |
| 82 | MP0001790_abnormal_immune_system | 1.18156431 |
| 83 | MP0002734_abnormal_mechanical_nocicepti | 1.17810459 |
| 84 | MP0003938_abnormal_ear_development | 1.17744700 |
| 85 | MP0003690_abnormal_glial_cell | 1.17469871 |
| 86 | MP0008961_abnormal_basal_metabolism | 1.17334015 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 1.15829541 |
| 88 | MP0003195_calcinosis | 1.15726575 |
| 89 | MP0005671_abnormal_response_to | 1.13912622 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 1.12835419 |
| 91 | MP0002095_abnormal_skin_pigmentation | 1.12029077 |
| 92 | MP0001970_abnormal_pain_threshold | 1.10540179 |
| 93 | MP0002166_altered_tumor_susceptibility | 1.10426625 |
| 94 | MP0003183_abnormal_peptide_metabolism | 1.10124818 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 1.09675733 |
| 96 | MP0001835_abnormal_antigen_presentation | 1.08043063 |
| 97 | MP0006072_abnormal_retinal_apoptosis | 1.08016342 |
| 98 | MP0002735_abnormal_chemical_nociception | 1.07875889 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 1.05819469 |
| 100 | MP0000566_synostosis | 1.05308951 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 1.04284696 |
| 102 | MP0002419_abnormal_innate_immunity | 1.03872282 |
| 103 | MP0002184_abnormal_innervation | 1.03600596 |
| 104 | MP0004947_skin_inflammation | 1.02294118 |
| 105 | MP0010155_abnormal_intestine_physiology | 1.02142469 |
| 106 | MP0003698_abnormal_male_reproductive | 1.01618414 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 1.01506826 |
| 108 | MP0010678_abnormal_skin_adnexa | 1.01033090 |
| 109 | MP0000026_abnormal_inner_ear | 1.00267153 |
| 110 | MP0001800_abnormal_humoral_immune | 0.99627662 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.98735485 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.98461803 |
| 113 | MP0005164_abnormal_response_to | 0.97878740 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.97808555 |
| 115 | MP0002723_abnormal_immune_serum | 0.97424856 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.96454084 |
| 117 | MP0003787_abnormal_imprinting | 0.94022974 |
| 118 | MP0005025_abnormal_response_to | 0.92902418 |
| 119 | MP0003878_abnormal_ear_physiology | 0.92207130 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.92207130 |
| 121 | MP0008260_abnormal_autophagy | 0.91044873 |
| 122 | MP0002420_abnormal_adaptive_immunity | 0.90924472 |
| 123 | MP0001501_abnormal_sleep_pattern | 0.89913331 |
| 124 | MP0008469_abnormal_protein_level | 0.89536079 |
| 125 | MP0005646_abnormal_pituitary_gland | 0.89524676 |
| 126 | MP0009115_abnormal_fat_cell | 0.89331161 |
| 127 | MP0005310_abnormal_salivary_gland | 0.89208974 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.89197565 |
| 129 | MP0001819_abnormal_immune_cell | 0.88788138 |
| 130 | MP0003634_abnormal_glial_cell | 0.88267160 |
| 131 | MP0001929_abnormal_gametogenesis | 0.88125005 |
| 132 | MP0002752_abnormal_somatic_nervous | 0.87826196 |
| 133 | MP0002557_abnormal_social/conspecific_i | 0.87696883 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.87660204 |
| 135 | MP0001545_abnormal_hematopoietic_system | 0.87660204 |
| 136 | MP0005253_abnormal_eye_physiology | 0.87483706 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.86990702 |
| 138 | MP0000604_amyloidosis | 0.85650953 |
| 139 | MP0005645_abnormal_hypothalamus_physiol | 0.84548681 |
| 140 | MP0003045_fibrosis | 0.84475373 |
| 141 | MP0004484_altered_response_of | 0.84104088 |
| 142 | MP0002229_neurodegeneration | 0.83599025 |
| 143 | MP0009785_altered_susceptibility_to | 0.83520607 |
| 144 | MP0001851_eye_inflammation | 0.81332136 |
| 145 | MP0004924_abnormal_behavior | 0.81037079 |
| 146 | MP0005386_behavior/neurological_phenoty | 0.81037079 |
| 147 | MP0000462_abnormal_digestive_system | 0.78511351 |
| 148 | MP0003632_abnormal_nervous_system | 0.76062208 |
| 149 | MP0002653_abnormal_ependyma_morphology | 0.74450599 |
| 150 | MP0001919_abnormal_reproductive_system | 0.74393612 |
| 151 | MP0005408_hypopigmentation | 0.72266725 |
| 152 | MP0001324_abnormal_eye_pigmentation | 0.71442491 |
| 153 | MP0003252_abnormal_bile_duct | 0.68897519 |
| 154 | MP0002075_abnormal_coat/hair_pigmentati | 0.67781968 |
| 155 | MP0002332_abnormal_exercise_endurance | 0.66944906 |
| 156 | MP0003121_genomic_imprinting | 0.65949289 |
| 157 | MP0008007_abnormal_cellular_replicative | 0.64299997 |
| 158 | MP0004043_abnormal_pH_regulation | 0.61155410 |
| 159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60484008 |
| 160 | MP0005389_reproductive_system_phenotype | 0.57229200 |
| 161 | MP0000249_abnormal_blood_vessel | 0.56556620 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.55466363 |
| 163 | MP0003795_abnormal_bone_structure | 0.55365559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.57528592 |
| 2 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.41114802 |
| 3 | Volvulus (HP:0002580) | 4.07954744 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.03848792 |
| 5 | Parakeratosis (HP:0001036) | 3.75352951 |
| 6 | T lymphocytopenia (HP:0005403) | 3.74002891 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.73375016 |
| 8 | Myositis (HP:0100614) | 3.71350561 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.68015862 |
| 10 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.50794664 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49886142 |
| 12 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.42351527 |
| 13 | Orchitis (HP:0100796) | 3.41493250 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.38522063 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.33943896 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33830323 |
| 17 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.29090751 |
| 18 | Recurrent skin infections (HP:0001581) | 3.27512339 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.25850678 |
| 20 | Abnormality of T cells (HP:0002843) | 3.23550236 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.17257250 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.17257250 |
| 23 | Albinism (HP:0001022) | 3.15761379 |
| 24 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.15628138 |
| 25 | Absent/shortened dynein arms (HP:0200106) | 3.15628138 |
| 26 | Abnormality of the renal collecting system (HP:0004742) | 3.15371709 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.10300256 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.06728266 |
| 29 | White forelock (HP:0002211) | 2.99672133 |
| 30 | Patchy hypopigmentation of hair (HP:0011365) | 2.98516905 |
| 31 | Encephalitis (HP:0002383) | 2.86501563 |
| 32 | Eosinophilia (HP:0001880) | 2.86499315 |
| 33 | Leukocytosis (HP:0001974) | 2.86451505 |
| 34 | Abnormality of the axillary hair (HP:0100134) | 2.84570781 |
| 35 | Abnormality of secondary sexual hair (HP:0009888) | 2.84570781 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.83611983 |
| 37 | Abnormal ciliary motility (HP:0012262) | 2.82460104 |
| 38 | Sensory axonal neuropathy (HP:0003390) | 2.80938742 |
| 39 | Duplicated collecting system (HP:0000081) | 2.74208979 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.71737132 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.71205097 |
| 42 | Meningitis (HP:0001287) | 2.67884345 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.67320784 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.66545767 |
| 45 | Chest pain (HP:0100749) | 2.65136977 |
| 46 | Gingivitis (HP:0000230) | 2.63715471 |
| 47 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.60897300 |
| 48 | Abnormality of eosinophils (HP:0001879) | 2.60625299 |
| 49 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.60076490 |
| 50 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.58271321 |
| 51 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.58271321 |
| 52 | Abnormal hair whorl (HP:0010721) | 2.57578909 |
| 53 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.57014113 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.56597506 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.55035456 |
| 56 | Granulocytopenia (HP:0001913) | 2.53008662 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.52132852 |
| 58 | Syringomyelia (HP:0003396) | 2.51001730 |
| 59 | Spinal cord lesions (HP:0100561) | 2.51001730 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.50393243 |
| 61 | Exertional dyspnea (HP:0002875) | 2.49991021 |
| 62 | Hypothermia (HP:0002045) | 2.49388285 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.47391765 |
| 64 | Overriding aorta (HP:0002623) | 2.45988386 |
| 65 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44783507 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.44716670 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.41746333 |
| 68 | Chromsome breakage (HP:0040012) | 2.40066155 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.38274715 |
| 70 | Hemoptysis (HP:0002105) | 2.35265221 |
| 71 | Widely spaced teeth (HP:0000687) | 2.35244219 |
| 72 | Pustule (HP:0200039) | 2.34365266 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.30482322 |
| 74 | Pancreatic fibrosis (HP:0100732) | 2.24991776 |
| 75 | Recurrent viral infections (HP:0004429) | 2.24836729 |
| 76 | Periodontitis (HP:0000704) | 2.24467751 |
| 77 | Vasculitis (HP:0002633) | 2.24401371 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.21662482 |
| 79 | Cupped ear (HP:0000378) | 2.21307728 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.20065031 |
| 81 | Truncal obesity (HP:0001956) | 2.16918728 |
| 82 | Viral hepatitis (HP:0006562) | 2.15943793 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 2.14825551 |
| 84 | Arterial thrombosis (HP:0004420) | 2.10613893 |
| 85 | Hematochezia (HP:0002573) | 2.08953755 |
| 86 | Constricted visual fields (HP:0001133) | 2.06632115 |
| 87 | Ureteral obstruction (HP:0006000) | 2.04955715 |
| 88 | Ocular albinism (HP:0001107) | 2.04813660 |
| 89 | Morphological abnormality of the inner ear (HP:0011390) | 2.03980676 |
| 90 | Rimmed vacuoles (HP:0003805) | 2.03341452 |
| 91 | Flat cornea (HP:0007720) | 2.02103148 |
| 92 | Febrile seizures (HP:0002373) | 2.02009529 |
| 93 | IgG deficiency (HP:0004315) | 2.00903869 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.00364362 |
| 95 | Protruding tongue (HP:0010808) | 1.99857275 |
| 96 | Urticaria (HP:0001025) | 1.99366357 |
| 97 | Fair hair (HP:0002286) | 1.99046875 |
| 98 | Broad-based gait (HP:0002136) | 1.98062426 |
| 99 | Pancreatic cysts (HP:0001737) | 1.95885950 |
| 100 | Gait imbalance (HP:0002141) | 1.95773325 |
| 101 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93779670 |
| 102 | Chronic hepatic failure (HP:0100626) | 1.93049861 |
| 103 | Increased IgM level (HP:0003496) | 1.91015593 |
| 104 | Papilledema (HP:0001085) | 1.90683442 |
| 105 | Stomatitis (HP:0010280) | 1.90334143 |
| 106 | Pulmonary embolism (HP:0002204) | 1.90120538 |
| 107 | Peripheral hypomyelination (HP:0007182) | 1.89925972 |
| 108 | Gingival bleeding (HP:0000225) | 1.89805225 |
| 109 | Thyroiditis (HP:0100646) | 1.89446847 |
| 110 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89426694 |
| 111 | Hypochromic anemia (HP:0001931) | 1.88535650 |
| 112 | Rhinitis (HP:0012384) | 1.87880572 |
| 113 | Absent speech (HP:0001344) | 1.87590798 |
| 114 | Congenital primary aphakia (HP:0007707) | 1.86310175 |
| 115 | Long clavicles (HP:0000890) | 1.84858294 |
| 116 | Abnormality of the corticospinal tract (HP:0002492) | 1.84550197 |
| 117 | True hermaphroditism (HP:0010459) | 1.83977904 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83974748 |
| 119 | Gangrene (HP:0100758) | 1.81553074 |
| 120 | Hip dysplasia (HP:0001385) | 1.81399196 |
| 121 | Prostate neoplasm (HP:0100787) | 1.80797998 |
| 122 | Genital tract atresia (HP:0001827) | 1.79824790 |
| 123 | Epistaxis (HP:0000421) | 1.79558921 |
| 124 | Attenuation of retinal blood vessels (HP:0007843) | 1.79096931 |
| 125 | Stomach cancer (HP:0012126) | 1.78177091 |
| 126 | Chronic diarrhea (HP:0002028) | 1.77628293 |
| 127 | Insomnia (HP:0100785) | 1.77327941 |
| 128 | Subacute progressive viral hepatitis (HP:0006572) | 1.77152678 |
| 129 | Generalized hypopigmentation of hair (HP:0011358) | 1.77125736 |
| 130 | Vaginal atresia (HP:0000148) | 1.76863708 |
| 131 | Prolonged bleeding time (HP:0003010) | 1.76046111 |
| 132 | Progressive inability to walk (HP:0002505) | 1.75445450 |
| 133 | Mitochondrial inheritance (HP:0001427) | 1.75205234 |
| 134 | Molar tooth sign on MRI (HP:0002419) | 1.74406531 |
| 135 | Abnormality of midbrain morphology (HP:0002418) | 1.74406531 |
| 136 | Spondylolisthesis (HP:0003302) | 1.73143100 |
| 137 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73095653 |
| 138 | Obstructive lung disease (HP:0006536) | 1.73095653 |
| 139 | Elfin facies (HP:0004428) | 1.72922865 |
| 140 | Alveolar cell carcinoma (HP:0006519) | 1.72664783 |
| 141 | Prominent nose (HP:0000448) | 1.72647272 |
| 142 | Abnormality of the diencephalon (HP:0010662) | 1.71798987 |
| 143 | Retrobulbar optic neuritis (HP:0100654) | 1.71314283 |
| 144 | Optic neuritis (HP:0100653) | 1.71314283 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.71285532 |
| 146 | Hyperventilation (HP:0002883) | 1.71194812 |
| 147 | Generalized hypopigmentation (HP:0007513) | 1.71005279 |
| 148 | Nephronophthisis (HP:0000090) | 1.70478750 |
| 149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68751697 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68751697 |
| 151 | Iris hypopigmentation (HP:0007730) | 1.65715805 |
| 152 | Ureteral stenosis (HP:0000071) | 1.64556865 |
| 153 | Recurrent abscess formation (HP:0002722) | 1.64520635 |
| 154 | Esotropia (HP:0000565) | 1.64425110 |
| 155 | Blue irides (HP:0000635) | 1.63699294 |
| 156 | Erythroderma (HP:0001019) | 1.61590548 |
| 157 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.60600602 |
| 158 | Flat occiput (HP:0005469) | 1.59935618 |
| 159 | Submucous cleft hard palate (HP:0000176) | 1.59568619 |
| 160 | Reticulocytopenia (HP:0001896) | 1.59564191 |
| 161 | Abnormal glycosylation (HP:0012345) | 1.58820303 |
| 162 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.58820303 |
| 163 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.58820303 |
| 164 | Abnormal protein glycosylation (HP:0012346) | 1.58820303 |
| 165 | Cutaneous melanoma (HP:0012056) | 1.58677110 |
| 166 | Abnormality of the columella (HP:0009929) | 1.58331908 |
| 167 | Nasolacrimal duct obstruction (HP:0000579) | 1.58313731 |
| 168 | Decreased central vision (HP:0007663) | 1.58106635 |
| 169 | Neurofibrillary tangles (HP:0002185) | 1.57786344 |
| 170 | Tented upper lip vermilion (HP:0010804) | 1.57705150 |
| 171 | Aganglionic megacolon (HP:0002251) | 1.56648757 |
| 172 | Optic disc pallor (HP:0000543) | 1.56346838 |
| 173 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.55045559 |
| 174 | Anomalous pulmonary venous return (HP:0010772) | 1.55044689 |
| 175 | Recurrent sinusitis (HP:0011108) | 1.54407582 |
| 176 | Retinal dysplasia (HP:0007973) | 1.54153768 |
| 177 | Respiratory difficulties (HP:0002880) | 1.53599364 |
| 178 | Hypomagnesemia (HP:0002917) | 1.51983481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LIMK1 | 4.19229399 |
| 2 | MAP3K9 | 3.22296714 |
| 3 | FRK | 3.05279120 |
| 4 | IRAK3 | 2.86892764 |
| 5 | PNCK | 2.79096710 |
| 6 | CASK | 2.77726124 |
| 7 | IRAK4 | 2.69025487 |
| 8 | TNIK | 2.40815800 |
| 9 | STK39 | 2.31761088 |
| 10 | STK16 | 2.02819070 |
| 11 | MAP4K2 | 1.91656259 |
| 12 | CSK | 1.89122705 |
| 13 | RIPK4 | 1.87168894 |
| 14 | CAMKK2 | 1.82336503 |
| 15 | JAK3 | 1.81486346 |
| 16 | MARK1 | 1.76620023 |
| 17 | FES | 1.73448856 |
| 18 | PIK3CG | 1.71041861 |
| 19 | OXSR1 | 1.70860824 |
| 20 | IRAK2 | 1.67965041 |
| 21 | GRK7 | 1.64170394 |
| 22 | TXK | 1.60590873 |
| 23 | MAP3K12 | 1.60333039 |
| 24 | CDC42BPA | 1.57714217 |
| 25 | ADRBK2 | 1.56556853 |
| 26 | IKBKE | 1.55868112 |
| 27 | BMPR1B | 1.55136556 |
| 28 | PLK4 | 1.53858539 |
| 29 | PKN1 | 1.52695712 |
| 30 | JAK1 | 1.47725203 |
| 31 | FGR | 1.47037706 |
| 32 | MUSK | 1.46375416 |
| 33 | MST4 | 1.45440932 |
| 34 | TEC | 1.35735085 |
| 35 | BMPR2 | 1.35239848 |
| 36 | SGK2 | 1.34076368 |
| 37 | ZAK | 1.33899352 |
| 38 | ROCK2 | 1.33091115 |
| 39 | MAPKAPK5 | 1.31341920 |
| 40 | VRK1 | 1.30285868 |
| 41 | SRPK1 | 1.29905747 |
| 42 | TYK2 | 1.29157097 |
| 43 | AKT3 | 1.24808715 |
| 44 | TLK1 | 1.24363862 |
| 45 | CSNK1G3 | 1.23021888 |
| 46 | EPHA3 | 1.21488998 |
| 47 | ZAP70 | 1.20489007 |
| 48 | CLK1 | 1.19222204 |
| 49 | CSNK1A1L | 1.17107030 |
| 50 | MKNK2 | 1.16344624 |
| 51 | SGK3 | 1.13204114 |
| 52 | MAPK13 | 1.11053964 |
| 53 | PTK2B | 1.09601050 |
| 54 | IRAK1 | 1.07568698 |
| 55 | JAK2 | 1.06066072 |
| 56 | YES1 | 1.05551211 |
| 57 | NLK | 1.05511917 |
| 58 | NEK6 | 1.04876141 |
| 59 | NUAK1 | 1.04322273 |
| 60 | CSF1R | 1.00053725 |
| 61 | KSR1 | 0.99154097 |
| 62 | BLK | 0.96895073 |
| 63 | CAMK2B | 0.96384992 |
| 64 | MAP3K14 | 0.95408721 |
| 65 | PBK | 0.93822410 |
| 66 | CDK19 | 0.93107047 |
| 67 | EIF2AK3 | 0.88413615 |
| 68 | PRKCH | 0.87595911 |
| 69 | FGFR3 | 0.87416233 |
| 70 | KIT | 0.86722476 |
| 71 | MATK | 0.86152200 |
| 72 | MAP3K13 | 0.84152957 |
| 73 | CSNK1G1 | 0.83172678 |
| 74 | GRK5 | 0.82275615 |
| 75 | BRD4 | 0.82036918 |
| 76 | NTRK2 | 0.81736733 |
| 77 | MKNK1 | 0.81479944 |
| 78 | EPHA4 | 0.77453410 |
| 79 | RPS6KA5 | 0.77241142 |
| 80 | MAP3K2 | 0.76962142 |
| 81 | DYRK2 | 0.76601753 |
| 82 | TGFBR2 | 0.76344244 |
| 83 | PRKCQ | 0.76320444 |
| 84 | CSNK1G2 | 0.76312029 |
| 85 | SYK | 0.75624360 |
| 86 | STK10 | 0.74638652 |
| 87 | CAMK2D | 0.74145072 |
| 88 | LCK | 0.73842428 |
| 89 | NTRK3 | 0.70062318 |
| 90 | PLK2 | 0.69915198 |
| 91 | CDK8 | 0.69068992 |
| 92 | PRKCE | 0.68880304 |
| 93 | STK4 | 0.68726613 |
| 94 | CDK3 | 0.68394714 |
| 95 | SGK494 | 0.68076491 |
| 96 | SGK223 | 0.68076491 |
| 97 | PIM1 | 0.67355763 |
| 98 | DAPK2 | 0.66665584 |
| 99 | TAOK3 | 0.66403444 |
| 100 | TNK2 | 0.65879528 |
| 101 | MAP2K7 | 0.64478940 |
| 102 | GRK1 | 0.62962431 |
| 103 | MAP2K3 | 0.60893422 |
| 104 | LYN | 0.60794440 |
| 105 | CAMK2A | 0.59469156 |
| 106 | BCR | 0.59221842 |
| 107 | CDK6 | 0.58266465 |
| 108 | MELK | 0.56958088 |
| 109 | CDK9 | 0.53710599 |
| 110 | CDK12 | 0.53236729 |
| 111 | CHEK2 | 0.52704573 |
| 112 | FYN | 0.52224590 |
| 113 | NEK9 | 0.51150960 |
| 114 | TBK1 | 0.50962374 |
| 115 | EIF2AK2 | 0.49757971 |
| 116 | CHUK | 0.48814371 |
| 117 | ABL1 | 0.48736406 |
| 118 | PDK1 | 0.48392141 |
| 119 | IKBKB | 0.46172272 |
| 120 | MAPKAPK2 | 0.46141825 |
| 121 | SIK2 | 0.45661576 |
| 122 | PIK3CA | 0.45386545 |
| 123 | CAMK1G | 0.44725188 |
| 124 | HCK | 0.44607887 |
| 125 | WNK1 | 0.44594724 |
| 126 | CSNK1A1 | 0.44066102 |
| 127 | WNK4 | 0.44023148 |
| 128 | MAPK7 | 0.43758508 |
| 129 | MAP4K1 | 0.43640867 |
| 130 | MAP3K1 | 0.43407528 |
| 131 | MOS | 0.41700974 |
| 132 | ATM | 0.41644849 |
| 133 | MAP3K7 | 0.41216612 |
| 134 | NME1 | 0.39220364 |
| 135 | MARK3 | 0.39158832 |
| 136 | PINK1 | 0.38435985 |
| 137 | PRKG1 | 0.38315000 |
| 138 | PRKD2 | 0.37785993 |
| 139 | PAK3 | 0.37296532 |
| 140 | PRPF4B | 0.36417430 |
| 141 | EPHB1 | 0.35893109 |
| 142 | ITK | 0.35189178 |
| 143 | RPS6KA4 | 0.34751767 |
| 144 | BTK | 0.33818043 |
| 145 | SGK1 | 0.33478751 |
| 146 | GRK6 | 0.33366783 |
| 147 | CDK4 | 0.31914273 |
| 148 | BRAF | 0.31815382 |
| 149 | MAP3K4 | 0.31642688 |
| 150 | ADRBK1 | 0.31218195 |
| 151 | DYRK1A | 0.30777319 |
| 152 | RAF1 | 0.30434180 |
| 153 | PLK3 | 0.30433534 |
| 154 | TTK | 0.30290854 |
| 155 | STK11 | 0.30169223 |
| 156 | TAF1 | 0.28807527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.63847216 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.57058347 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.21079010 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15100857 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 1.89890341 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 1.86704415 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86086829 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.77158557 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.75986966 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73399632 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.70346733 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68414330 |
| 13 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62269745 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.61245768 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58483118 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.56242902 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50710038 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.48511593 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47287151 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.45463113 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45246456 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.41563675 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.41266404 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38232754 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37694358 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.37235798 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33681805 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.32922793 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31106636 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31027522 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30878981 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30649773 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.29849577 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29561849 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.28516780 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.27394052 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.23940534 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23813905 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22465895 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.21868209 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20746927 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20736605 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.20461346 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.19733190 |
| 45 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19431220 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.18761126 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18724675 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.18117016 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16716910 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16504214 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14320806 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12804287 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.10958105 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10795277 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07991837 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06467660 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06010533 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03758177 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 1.02948277 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99648550 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99263240 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.98674528 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98670035 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97581560 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93979037 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93168927 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92939996 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92706410 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90256405 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89148170 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88369001 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88088294 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87838721 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.87251420 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85336747 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84738153 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83964601 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.83898076 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82689193 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81931348 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81097470 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81003760 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80364729 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80249104 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.79880080 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77604704 |
| 87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76745865 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.76672636 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76318621 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76205131 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75152681 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.74921464 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74617733 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72613379 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.71436197 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71281144 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71104284 |
| 98 | Spliceosome_Homo sapiens_hsa03040 | 0.71061370 |
| 99 | DNA replication_Homo sapiens_hsa03030 | 0.70685127 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68955195 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.68893139 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68847847 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68538017 |
| 104 | Prostate cancer_Homo sapiens_hsa05215 | 0.67881529 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67346065 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67057333 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66966976 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66125531 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65986727 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65772112 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.64728158 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.64599670 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64298141 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.64033504 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63348788 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61509496 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.59352509 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59343503 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58806929 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58097631 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56801252 |
| 122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.56376617 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56267196 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54318084 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.53289396 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52124158 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51758465 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51113539 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49442218 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49003715 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48605793 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48563566 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47768533 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46060815 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45718931 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45584004 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45179293 |
| 138 | Proteasome_Homo sapiens_hsa03050 | 0.43983170 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43647223 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.43441871 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43148147 |
| 142 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42412611 |
| 143 | Endocytosis_Homo sapiens_hsa04144 | 0.42189070 |
| 144 | ABC transporters_Homo sapiens_hsa02010 | 0.41201426 |
| 145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41078472 |
| 146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40457826 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40236010 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39976151 |
| 149 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39051246 |
| 150 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36988073 |
| 151 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36625663 |
| 152 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36125339 |
| 153 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35904947 |
| 154 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35248400 |
| 155 | Tuberculosis_Homo sapiens_hsa05152 | 0.35035029 |

